Unknown

Dataset Information

0

Improving anticoagulation management in patients with atrial fibrillation.


ABSTRACT: Three agents have recently been approved to reduce the risk of stroke and embolism, and one agent is in phase 3 trials. These drugs cause less serious bleeding and are simpler to manage, compared with warfarin, but they are not without their risks.

SUBMITTER: Fanikos JR 

PROVIDER: S-EPMC3638402 | biostudies-other | 2013 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Improving anticoagulation management in patients with atrial fibrillation.

Fanikos John R JR   Atay Julie K JK   Connors Jean M JM  

P & T : a peer-reviewed journal for formulary management 20130301 3


Three agents have recently been approved to reduce the risk of stroke and embolism, and one agent is in phase 3 trials. These drugs cause less serious bleeding and are simpler to manage, compared with warfarin, but they are not without their risks. ...[more]

Similar Datasets

| S-EPMC4711491 | biostudies-other
| S-EPMC2704137 | biostudies-literature
| S-EPMC7347083 | biostudies-literature
| S-EPMC5108189 | biostudies-other
| S-EPMC4931686 | biostudies-literature
| S-EPMC4264672 | biostudies-literature
| S-EPMC5538221 | biostudies-other
| S-EPMC8360426 | biostudies-literature